Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 24 Carcinoma, Non-Small-Cell Lung 15 Colorectal Neoplasms 13 Neoplasms 12 Lung Neoplasms 12 Stomach Neoplasms 9 Neoplasm Metastasis 6 Colonic Neoplasms 6 Esophageal Neoplasms 5 Small Cell Lung Carcinoma 4 Pancreatic Neoplasms 4 Leukemia, Myeloid, Acute 4 Head and Neck Neoplasms 4 Esophageal Squamous Cell Carcinoma 4 Urinary Bladder Neoplasms 3 Triple Negative Breast Neoplasms 3 Sarcoma 3 Ovarian Neoplasms 3 Osteosarcoma 3 Multiple Myeloma 3 Melanoma 3 Lymphoma, Follicular 3 Lymphoma 3 Waldenstrom Macroglobulinemia 2 Vulvar Neoplasms 2 Uterine Cervical Neoplasms 2 Thymus Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Recurrence 2 Rectal Neoplasms 2

Interventions

palbociclib 1 Fulvestrant 1 Drug Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × HER2-positive Metastatic Breast Cancer × Drug Therapy × Clear all

NCT05188495 2022-01-12

HELP

Peking University Cancer Hospital & Institute

HER2-positive Metastatic Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡